FDA Approves Chemo Patient Anti-Nausea Patch

by: cancercompass

Cancer patients will soon get additional help combating nausea, one of the most common side effects associated with chemotherapy treatment.

Yesterday the U.S. Food and Drug Administration announced its approval of the first anti-nausea patch for patients undergoing chemotherapy.

The patch is called Sancuso. Worn on the upper arm, Sancuso delivers a steady dose of the anti-nausea drug granisetron for a period of five days.

The Sancuso patch was developed by ProStraken, a Scotland-based company. The patch is expected to be available to chemotherapy patients by the end of this year.